Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Hiring Campaign Continues; Goal Is Addressing Pending ANDAs

Executive Summary

GDUFA funding will bring 50 additional people to the Office of Pharmaceutical Quality for generic drug review purposes.

You may also be interested in...



ANDA Submissions Continue Yo-Yo Pattern, Unlike Approvals

After spike in March, generic drug application submissions drop 62% in April, while approval volume remains at monthly average.

ANDA Submissions Continue Yo-Yo Pattern, Unlike Approvals

After spike in March, generic drug application submissions drop 62% in April, while approval volume remains at monthly average.

A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?

Industry worries about user fee programs as US FDA could wait weeks before finding out how President Trump's hiring freeze affects it.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS119207

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel